Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 10,377,000 | 9,964,000 | 10,241,000 | 10,143,000 | 9,978,000 |
| Cost of Goods | 4,603,000 | 4,463,000 | 4,556,000 | 4,605,000 | 4,483,000 |
| Gross Profit | 5,774,000 | 5,501,000 | 5,685,000 | 5,538,000 | 5,495,000 |
| Operating Expenses | 4,105,000 | 4,115,000 | 3,905,000 | 3,891,000 | 3,953,000 |
| Operating Income | 1,669,000 | 1,386,000 | 1,780,000 | 1,647,000 | 1,542,000 |
| Interest Expense | 140,000 | 141,000 | 159,000 | 166,000 | 159,000 |
| Other Income | 78,000 | 191,000 | 174,000 | 190,000 | 253,000 |
| Pre-tax Income | 1,607,000 | 1,436,000 | 1,795,000 | 1,671,000 | 1,636,000 |
| Income Tax | 305,000 | 211,000 | 201,000 | 235,000 | 261,000 |
| Net Income Continuous | 1,302,000 | 1,225,000 | 1,594,000 | 1,436,000 | 1,375,000 |
| Net Income | $1,302,000 | $1,225,000 | $1,594,000 | $1,436,000 | $1,375,000 |
| EPS Basic Total Ops | 0.74 | 0.70 | 0.92 | 0.82 | 0.79 |
| EPS Basic Continuous Ops | 0.75 | 0.70 | 0.92 | 0.83 | 0.79 |
| EPS Diluted Total Ops | 0.74 | 0.70 | 0.91 | 0.82 | 0.78 |
| EPS Diluted Continuous Ops | 0.74 | 0.70 | 0.91 | 0.82 | 0.79 |
| EPS Diluted Before Non-Recurring Items | 1.14 | 0.98 | 1.19 | N/A | N/A |
| EBITDA(a) | $2,474,000 | $2,191,000 | $2,593,000 | $2,471,000 | $2,342,000 |